Equities research analysts expect Sharps Compliance Corp. (NASDAQ:SMED) to announce $12.11 million in sales for the current quarter, according to Zacks Investment Research. Three analysts have provided estimates for Sharps Compliance’s earnings. The lowest sales estimate is $11.50 million and the highest is $12.42 million. Sharps Compliance reported sales of $12.39 million during the same quarter last year, which suggests a negative year-over-year growth rate of 2.3%. The firm is scheduled to issue its next quarterly earnings results on Wednesday, January 22nd.
On average, analysts expect that Sharps Compliance will report full-year sales of $48.81 million for the current financial year, with estimates ranging from $48.60 million to $49.04 million. For the next year, analysts expect that the firm will post sales of $52.50 million, with estimates ranging from $51.41 million to $53.60 million. Zacks Investment Research’s sales calculations are an average based on a survey of research analysts that that provide coverage for Sharps Compliance.
Sharps Compliance (NASDAQ:SMED) last posted its quarterly earnings results on Wednesday, October 23rd. The industrial products company reported $0.04 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.01 by $0.03. Sharps Compliance had a net margin of 1.74% and a return on equity of 3.16%. The company had revenue of $13.60 million for the quarter, compared to the consensus estimate of $11.30 million.
Hedge funds and other institutional investors have recently modified their holdings of the stock. BlackRock Inc. boosted its stake in shares of Sharps Compliance by 3.8% during the second quarter. BlackRock Inc. now owns 108,739 shares of the industrial products company’s stock valued at $387,000 after purchasing an additional 4,013 shares in the last quarter. Lapides Asset Management LLC boosted its position in shares of Sharps Compliance by 13.3% during the second quarter. Lapides Asset Management LLC now owns 164,700 shares of the industrial products company’s stock valued at $586,000 after buying an additional 19,300 shares during the last quarter. Morgan Stanley boosted its position in Sharps Compliance by 34.3% in the second quarter. Morgan Stanley now owns 188,699 shares of the industrial products company’s stock worth $672,000 after purchasing an additional 48,199 shares during the last quarter. North Star Investment Management Corp. boosted its position in Sharps Compliance by 9.8% in the third quarter. North Star Investment Management Corp. now owns 271,575 shares of the industrial products company’s stock worth $1,127,000 after purchasing an additional 24,150 shares during the last quarter. Finally, Wells Fargo & Company MN lifted its position in shares of Sharps Compliance by 8.3% during the 2nd quarter. Wells Fargo & Company MN now owns 424,814 shares of the industrial products company’s stock valued at $1,512,000 after buying an additional 32,600 shares during the last quarter. Institutional investors own 17.23% of the company’s stock.
Shares of SMED stock traded down $0.15 during trading hours on Friday, reaching $4.10. The stock had a trading volume of 89,000 shares, compared to its average volume of 21,659. The firm has a market capitalization of $71.37 million, a PE ratio of 410.00, a price-to-earnings-growth ratio of 3.27 and a beta of 0.28. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.99 and a quick ratio of 1.66. The firm has a 50-day simple moving average of $4.44 and a 200-day simple moving average of $3.81. Sharps Compliance has a twelve month low of $2.97 and a twelve month high of $5.25.
About Sharps Compliance
Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste and used healthcare materials generated outside the hospital and health care facility settings; TakeAway Medication Recovery System, a solution that facilitates the proper disposal of unused medications; MedSafe, a solution for the safe collection, transportation, and proper disposal of unwanted and expired prescription medications; and ComplianceTRAC, a Web-based compliance and training program.
Further Reading: How do taxes affect a CDs total return?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sharps Compliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Compliance and related companies with MarketBeat.com's FREE daily email newsletter.